| Product NDC: | 67386-601 |
| Proprietary Name: | Peganone |
| Non Proprietary Name: | ethotoin |
| Active Ingredient(s): | 250 mg/1 & nbsp; ethotoin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 67386-601 |
| Labeler Name: | Lundbeck Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA010841 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19570422 |
| Package NDC: | 67386-601-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (67386-601-01) |
| NDC Code | 67386-601-01 |
| Proprietary Name | Peganone |
| Package Description | 100 TABLET in 1 BOTTLE (67386-601-01) |
| Product NDC | 67386-601 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ethotoin |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19570422 |
| Marketing Category Name | NDA |
| Labeler Name | Lundbeck Inc. |
| Substance Name | ETHOTOIN |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |